Campath

Active Ingredient(s): Alemtuzumab
FDA Approved: * May 7, 2001
Pharm Company: * ILEX PHARMACEUTICALS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Campath Overview

Alemtuzumab is a drug used in the treatment of chronic lymphocytic leukemia (CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma under the trade names Campath, MabCampath and Campath-1H, and in the treatment of multiple sclerosis as Lemtrada. It is also used as an anti-rejection agent in some conditioning regimens for bone marrow transplantation, kidney transplantation and islet cell transplantation. It is a monoclonal antibody that binds to CD52, a protein present on the surface of ma...

Read more Campath Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Alemtuzumab

Recent Campath Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Alemtuzumab
  • Injection: 10mg/ml, 12mg/1.2ml (10mg/ml), 30mg/ml
  • Vial: 10mg/ml, 30mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Campath: (1 result)

Sorted by National Drug Code
  • 58468-0357 Campath 30 mg/ml Intravenous Injection by Genzyme Corporation

Other drugs which contain Alemtuzumab or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 10 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA